drugset / Press release
EvolveImmune Therapeutics to Present Update on Lead Asset EVOLVE104 and New Data for EVOLVE T Cell Engager Platform at 2026 AACR Annual Meeting
2026-04-14 · EvolveImmune United, Inc · original evolveimmune.com ↗
April 14, 2026 07:00 ET | Source: EvolveImmune Therapeutics
The release as fetched from its publisher. evolveimmune.com ↗